InvestorsObserver
×
News Home

Should Edwards Lifesciences Corp (EW) be in Your Portfolio?

Friday, September 25, 2020 11:48 AM | InvestorsObserver Analysts

Mentioned in this article

Should Edwards Lifesciences Corp (EW) be in Your Portfolio?

Edwards Lifesciences Corp (EW) is near the top in its industry group according to InvestorsObserver. EW gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Edwards Lifesciences Corp gets a 78 rank in the Medical Devices industry. Medical Devices is number 66 out of 148 industries.

Overall Score - 57
EW has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on EW!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Edwards Lifesciences Corp Stock Today?

Edwards Lifesciences Corp (EW) stock is trading at $75.96 as of 11:42 AM on Friday, Sep 25, a gain of $1.29, or 1.73% from the previous closing price of $74.67. The stock has traded between $74.07 and $76.16 so far today. Volume today is less active than usual. So far 634,831 shares have traded compared to average volume of 2,610,368 shares.

Click Here to get the full Stock Score Report on Edwards Lifesciences Corp (EW) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App